CIC
Carnegie Investment Counsel’s SPDR S&P Biotech ETF XBI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.11M | Sell |
49,615
-1,830
| -4% | -$152K | 0.08% | 183 |
|
2025
Q1 | $3.76M | Sell |
51,445
-49,661
| -49% | -$3.62M | 0.09% | 175 |
|
2024
Q4 | $9.11M | Buy |
101,106
+5,683
| +6% | +$512K | 0.26% | 103 |
|
2024
Q3 | $9.43M | Buy |
95,423
+2,975
| +3% | +$294K | 0.28% | 97 |
|
2024
Q2 | $8.57M | Buy |
92,448
+9,055
| +11% | +$839K | 0.27% | 99 |
|
2024
Q1 | $7.91M | Buy |
83,393
+20,282
| +32% | +$1.92M | 0.25% | 103 |
|
2023
Q4 | $5.64M | Sell |
63,111
-34,429
| -35% | -$3.07M | 0.19% | 125 |
|
2023
Q3 | $7.12M | Sell |
97,540
-4,067
| -4% | -$297K | 0.27% | 98 |
|
2023
Q2 | $8.45M | Buy |
101,607
+6,075
| +6% | +$505K | 0.31% | 93 |
|
2023
Q1 | $7.28M | Sell |
95,532
-1,627
| -2% | -$124K | 0.29% | 98 |
|
2022
Q4 | $8.06M | Buy |
97,159
+2,109
| +2% | +$175K | 0.35% | 81 |
|
2022
Q3 | $7.54M | Buy |
95,050
+11,767
| +14% | +$933K | 0.36% | 81 |
|
2022
Q2 | $6.19M | Sell |
83,283
-29,403
| -26% | -$2.18M | 0.28% | 99 |
|
2022
Q1 | $10.1M | Buy |
112,686
+19,050
| +20% | +$1.71M | 0.37% | 81 |
|
2021
Q4 | $10.5M | Sell |
93,636
-16,368
| -15% | -$1.83M | 0.35% | 88 |
|
2021
Q3 | $13.8M | Buy |
110,004
+6,973
| +7% | +$877K | 0.52% | 64 |
|
2021
Q2 | $14M | Buy |
103,031
+18,083
| +21% | +$2.45M | 0.53% | 62 |
|
2021
Q1 | $11.5M | Buy |
84,948
+7,813
| +10% | +$1.06M | 0.48% | 67 |
|
2020
Q4 | $10.9M | Buy |
77,135
+1,601
| +2% | +$225K | 0.49% | 66 |
|
2020
Q3 | $8.42M | Buy |
75,534
+190
| +0.3% | +$21.2K | 0.43% | 71 |
|
2020
Q2 | $8.43M | Buy |
75,344
+1,943
| +3% | +$217K | 0.48% | 61 |
|
2020
Q1 | $5.68M | Sell |
73,401
-27,300
| -27% | -$2.11M | 0.39% | 76 |
|
2019
Q4 | $9.58M | Buy |
100,701
+153
| +0.2% | +$14.6K | 0.55% | 54 |
|
2019
Q3 | $7.67M | Sell |
100,548
-5,124
| -5% | -$391K | 0.49% | 63 |
|
2019
Q2 | $9.27M | Buy |
105,672
+6,617
| +7% | +$580K | 0.6% | 47 |
|
2019
Q1 | $8.97M | Buy |
99,055
+2,717
| +3% | +$246K | 0.62% | 48 |
|
2018
Q4 | $6.91M | Sell |
96,338
-42,221
| -30% | -$3.03M | 0.64% | 42 |
|
2018
Q3 | $11.1M | Buy |
138,559
+39,031
| +39% | +$3.12M | 0.91% | 31 |
|
2018
Q2 | $9.44M | Buy |
99,528
+2,233
| +2% | +$212K | 0.72% | 42 |
|
2018
Q1 | $8.92M | Buy |
97,295
+1,906
| +2% | +$175K | 0.75% | 41 |
|
2017
Q4 | $8.72M | Buy |
95,389
+4,313
| +5% | +$394K | 0.77% | 36 |
|
2017
Q3 | $7.69M | Buy |
91,076
+2,021
| +2% | +$171K | 0.9% | 29 |
|
2017
Q2 | $6.87M | Buy |
89,055
+4,194
| +5% | +$324K | 0.84% | 33 |
|
2017
Q1 | $5.87M | Buy |
84,861
+3,196
| +4% | +$221K | 0.73% | 44 |
|
2016
Q4 | $5.1M | Buy |
81,665
+49,830
| +157% | +$3.11M | 0.68% | 50 |
|
2016
Q3 | $1.88M | Buy |
31,835
+25,340
| +390% | +$1.5M | 0.27% | 104 |
|
2016
Q2 | $400K | Buy |
+6,495
| New | +$400K | 0.06% | 240 |
|
2014
Q2 | – | Sell |
-2,753
| Closed | -$392K | – | 233 |
|
2014
Q1 | $392K | Sell |
2,753
-19,274
| -88% | -$2.74M | 0.1% | 158 |
|
2013
Q4 | $2.87M | Buy |
22,027
+960
| +5% | +$125K | 0.77% | 49 |
|
2013
Q3 | $2.72M | Sell |
21,067
-1,246
| -6% | -$161K | 0.84% | 39 |
|
2013
Q2 | $2.33M | Buy |
+22,313
| New | +$2.33M | 0.76% | 47 |
|